Correlation Between Finch Therapeutics and XOMA
Can any of the company-specific risk be diversified away by investing in both Finch Therapeutics and XOMA at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Finch Therapeutics and XOMA into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Finch Therapeutics Group and XOMA Corporation, you can compare the effects of market volatilities on Finch Therapeutics and XOMA and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Finch Therapeutics with a short position of XOMA. Check out your portfolio center. Please also check ongoing floating volatility patterns of Finch Therapeutics and XOMA.
Diversification Opportunities for Finch Therapeutics and XOMA
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Finch and XOMA is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Finch Therapeutics Group and XOMA Corp. in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on XOMA and Finch Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Finch Therapeutics Group are associated (or correlated) with XOMA. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of XOMA has no effect on the direction of Finch Therapeutics i.e., Finch Therapeutics and XOMA go up and down completely randomly.
Pair Corralation between Finch Therapeutics and XOMA
If you would invest 2,510 in XOMA Corporation on December 28, 2024 and sell it today you would earn a total of 35.00 from holding XOMA Corporation or generate 1.39% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Flat |
Strength | Insignificant |
Accuracy | 0.0% |
Values | Daily Returns |
Finch Therapeutics Group vs. XOMA Corp.
Performance |
Timeline |
Finch Therapeutics |
Risk-Adjusted Performance
Very Weak
Weak | Strong |
XOMA |
Finch Therapeutics and XOMA Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Finch Therapeutics and XOMA
The main advantage of trading using opposite Finch Therapeutics and XOMA positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Finch Therapeutics position performs unexpectedly, XOMA can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in XOMA will offset losses from the drop in XOMA's long position.Finch Therapeutics vs. Werewolf Therapeutics | Finch Therapeutics vs. Edgewise Therapeutics | Finch Therapeutics vs. Celcuity LLC | Finch Therapeutics vs. C4 Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.
Other Complementary Tools
Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
Fundamental Analysis View fundamental data based on most recent published financial statements |